Status:
UNKNOWN
Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Chronic Hep B
Eligibility:
All Genders
18+ years
Brief Summary
This is a retrospective-prospective longitudinal cohort study, with analyses performed before and after introduction of the pathway, and comparisons made to unexposed controls. We will launch a protoc...
Detailed Description
Chronic viral hepatitis is the seventh leading cause of mortality globally, responsible for 1.45 million deaths in 2013. The consequences of chronic hepatitis B and C infection - cirrhosis and liver c...
Eligibility Criteria
Inclusion
- Adult patients with positive hepatitis B surface antigen (HBsAg) for 6 months
- Under the care of GOPC
Exclusion
- Age under 18
- Refusal to consent
Key Trial Info
Start Date :
May 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
3300 Patients enrolled
Trial Details
Trial ID
NCT04904900
Start Date
May 6 2021
End Date
December 31 2025
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong